|
chromosome organization
|
GO:0051276 |
360 |
0.091
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.080
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.060
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.058
|
|
|
dna metabolic process
|
GO:0006259 |
227 |
0.055
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.055
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.050
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.048
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.042
|
|
|
regulation of mrna processing
|
GO:0050684 |
71 |
0.041
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
260 |
0.040
|
|
|
protein localization
|
GO:0008104 |
284 |
0.038
|
|
|
regulation of rna splicing
|
GO:0043484 |
69 |
0.038
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.038
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.037
|
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.037
|
|
|
catabolic process
|
GO:0009056 |
409 |
0.035
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.033
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.033
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
240 |
0.029
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
72 |
0.028
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
3 |
0.027
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.027
|
|
|
rna processing
|
GO:0006396 |
147 |
0.027
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.027
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.026
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.026
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
64 |
0.026
|
|
|
mapk cascade
|
GO:0000165 |
107 |
0.026
|
|
|
response to external biotic stimulus
|
GO:0043207 |
293 |
0.025
|
|
|
cell cycle checkpoint
|
GO:0000075 |
95 |
0.025
|
|
|
cellular protein localization
|
GO:0034613 |
160 |
0.024
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.023
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.023
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.023
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.023
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
88 |
0.023
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.022
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
107 |
0.022
|
|
|
intracellular transport
|
GO:0046907 |
228 |
0.021
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.021
|
|
|
chromatin modification
|
GO:0016568 |
147 |
0.021
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.020
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.020
|
|
|
ras protein signal transduction
|
GO:0007265 |
88 |
0.020
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.020
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.020
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.019
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
277 |
0.019
|
|
|
eye development
|
GO:0001654 |
323 |
0.019
|
|
|
appendage morphogenesis
|
GO:0035107 |
397 |
0.019
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.019
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
60 |
0.018
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.017
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.017
|
|
|
negative regulation of developmental process
|
GO:0051093 |
201 |
0.017
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.016
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
93 |
0.016
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.016
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.015
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
61 |
0.015
|
|
|
eye morphogenesis
|
GO:0048592 |
260 |
0.015
|
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.015
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.015
|
|
|
regulation of phosphorylation
|
GO:0042325 |
147 |
0.015
|
|
|
rna splicing
|
GO:0008380 |
83 |
0.014
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
139 |
0.014
|
|
|
organic substance transport
|
GO:0071702 |
257 |
0.014
|
|
|
mrna metabolic process
|
GO:0016071 |
124 |
0.014
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.014
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
60 |
0.014
|
|
|
mrna processing
|
GO:0006397 |
104 |
0.014
|
|
|
stem cell development
|
GO:0048864 |
79 |
0.013
|
|
|
forebrain development
|
GO:0030900 |
2 |
0.013
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.013
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
249 |
0.013
|
|
|
regionalization
|
GO:0003002 |
416 |
0.013
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
243 |
0.013
|
|
|
negative regulation of cell division
|
GO:0051782 |
17 |
0.013
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
73 |
0.013
|
|
|
phosphorylation
|
GO:0016310 |
294 |
0.013
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.013
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
87 |
0.013
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
277 |
0.013
|
|
|
post embryonic appendage morphogenesis
|
GO:0035120 |
385 |
0.013
|
|
|
lateral inhibition
|
GO:0046331 |
206 |
0.013
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
69 |
0.013
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
73 |
0.012
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
116 |
0.012
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
139 |
0.012
|
|
|
death
|
GO:0016265 |
284 |
0.012
|
|
|
imaginal disc derived appendage development
|
GO:0048737 |
399 |
0.012
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.012
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.012
|
|
|
cell division
|
GO:0051301 |
248 |
0.012
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.012
|
|
|
gland development
|
GO:0048732 |
191 |
0.012
|
|
|
protein phosphorylation
|
GO:0006468 |
169 |
0.012
|
|
|
stem cell division
|
GO:0017145 |
69 |
0.012
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.012
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.012
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
156 |
0.012
|
|
|
organic acid metabolic process
|
GO:0006082 |
103 |
0.012
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
3 |
0.011
|
|
|
wing disc morphogenesis
|
GO:0007472 |
344 |
0.011
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.011
|
|
|
appendage development
|
GO:0048736 |
401 |
0.011
|
|
|
cytoplasmic transport
|
GO:0016482 |
130 |
0.011
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.011
|
|
|
leg disc development
|
GO:0035218 |
92 |
0.011
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.011
|
|
|
exocrine system development
|
GO:0035272 |
162 |
0.011
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.011
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.011
|
|
|
cellular response to organic substance
|
GO:0071310 |
132 |
0.011
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.011
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
24 |
0.011
|
|
|
amine metabolic process
|
GO:0009308 |
12 |
0.011
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.010
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.010
|
|
|
membrane organization
|
GO:0061024 |
112 |
0.010
|
|
|
response to organic substance
|
GO:0010033 |
284 |
0.010
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
87 |
0.010
|
|
|
covalent chromatin modification
|
GO:0016569 |
106 |
0.010
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
267 |
0.010
|
|
|
tissue morphogenesis
|
GO:0048729 |
297 |
0.010
|
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.010
|
|
|
regulation of mapk cascade
|
GO:0043408 |
92 |
0.010
|
|
|
single organism intracellular transport
|
GO:1902582 |
207 |
0.010
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.010
|
|
|
regulation of chromatin modification
|
GO:1903308 |
28 |
0.010
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.010
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
266 |
0.010
|
|
|
muscle structure development
|
GO:0061061 |
224 |
0.010
|
|
|
protein catabolic process
|
GO:0030163 |
101 |
0.010
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
52 |
0.010
|
|